PreEmptive Meds' Series C Round

PreEmptive Meds raised a round of funding on August 05, 2010. Investors include Capital Midwest Fund.

More than 50 million people have either fasting blood sugar or cholesterol which is higher than normal, but not severe enough to be considered diabetes or serious heart disease. This is referred to as…

Articles about PreEmptive Meds' Series C Round: